| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,153,025 | 2,058,274 | 1,531,408 | 1,105,607 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 2,058,274 | 1,531,408 | 1,105,607 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 562,948 | 1,562,304 | 1,434,848 | 1,494,928 | | Non Recurring |
-
|
-
|
-
| 989,971 | | Others | (332,340) | 333,269 | 465 | 742 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (113,859) | 162,701 | 96,095 | (1,380,034) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (111,093) | (17,285) | 24,624 | 1,595,842 | | Earnings Before Interest And Taxes | 55,149 | 138,077 | 120,719 | (1,236,839) | | Interest Expense | 53,469 | 54,198 | 61,341 | 84,247 | | Income Before Tax | 1,680 | 83,879 | 59,378 | (1,321,086) | | Income Tax Expense | 3,616 | 16,045 | 45,953 | 92,828 | | Minority Interest | 7 | 40 |
-
|
-
| | | | Net Income From Continuing Ops | (9,315) | 85,541 | 3,097 | (1,419,513) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 21,098 | 85,541 | 3,097 | (1,419,513) | | Preferred Stock And Other Adjustments | (244,316) | (5,592) | 175,282 | (13,645) | | | Net Income Applicable To Common Shares | ($11,402) | $79,949 | $178,379 | ($1,433,158) |
|
0.02% Nasdaq 
0.33%
Income Statement
